{
  "DOI": "10.1186/1479-7364-1-6-444",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/1479-7364-1-6-444",
  "alternative-id": [
    "79"
  ],
  "article-number": "444",
  "author": [
    {
      "affiliation": [],
      "family": "Milos",
      "given": "Patrice M",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Seymour",
      "given": "Albert B",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2019,
        12,
        11
      ]
    ],
    "date-time": "2019-12-11T02:26:39Z",
    "timestamp": 1576031199000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        12,
        11
      ]
    ],
    "date-time": "2019-12-11T02:26:44Z",
    "timestamp": 1576031204000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        8,
        19
      ]
    ],
    "date-time": "2023-08-19T10:37:38Z",
    "timestamp": 1692441458837
  },
  "is-referenced-by-count": 7,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2004,
        11,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2004,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2004,
            11,
            1
          ]
        ],
        "date-time": "2004-11-01T00:00:00Z",
        "timestamp": 1099267200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/1479-7364-1-6-444.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/1479-7364-1-6-444/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/1479-7364-1-6-444.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2004,
        11,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2004,
        11,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2004,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1126/science.278.5343.1580",
      "author": "FS Collins",
      "doi-asserted-by": "publisher",
      "first-page": "1580",
      "journal-title": "Science",
      "key": "79_CR1",
      "unstructured": "Collins FS, Guyer MS, Chakravarti A: Variations on a theme: Cataloging human DNA sequence variation. Science. 1997, 278: 1580-1581. 10.1126/science.278.5343.1580.",
      "volume": "278",
      "year": "1997"
    },
    {
      "DOI": "10.1038/885",
      "author": "A Chakravarti",
      "doi-asserted-by": "publisher",
      "first-page": "216",
      "journal-title": "Nat Genet",
      "key": "79_CR2",
      "unstructured": "Chakravarti A: It's raining SNPs, hallelujah?. Nat Genet. 1998, 19: 216-217. 10.1038/885.",
      "volume": "19",
      "year": "1998"
    },
    {
      "DOI": "10.1038/35057062",
      "author": "International Human Genome Sequencing Consortium",
      "doi-asserted-by": "publisher",
      "first-page": "860",
      "journal-title": "Nature",
      "key": "79_CR3",
      "unstructured": "International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature. 2001, 409: 860-921. 10.1038/35057062.",
      "volume": "409",
      "year": "2001"
    },
    {
      "DOI": "10.1126/science.1058040",
      "author": "JC Venter",
      "doi-asserted-by": "publisher",
      "first-page": "1304",
      "journal-title": "Science",
      "key": "79_CR4",
      "unstructured": "Venter JC, Adams MD, Myers EW, et al: The sequence of the human genome. Science. 2001, 291: 1304-1351. 10.1126/science.1058040.",
      "volume": "291",
      "year": "2001"
    },
    {
      "DOI": "10.1038/35057149",
      "author": "The International SNP Working Group",
      "doi-asserted-by": "publisher",
      "first-page": "928",
      "journal-title": "Nature",
      "key": "79_CR5",
      "unstructured": "The International SNP Working Group: A map of the human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001, 409: 928-933. 10.1038/35057149.",
      "volume": "409",
      "year": "2001"
    },
    {
      "key": "79_CR6",
      "unstructured": "The SNP Consortium. 2002, (Accessed 21st October, 2004), [\n                    http://snp.cshl.org/index.html\n                    \n                  ]"
    },
    {
      "DOI": "10.1038/nature02168",
      "author": "The International HapMap Consortium",
      "doi-asserted-by": "publisher",
      "first-page": "789",
      "journal-title": "Nature",
      "key": "79_CR7",
      "unstructured": "The International HapMap Consortium: The international HapMap project. Nature. 2003, 426: 789-796. 10.1038/nature02168.",
      "volume": "426",
      "year": "2003"
    },
    {
      "DOI": "10.1126/science.280.5366.1077",
      "author": "DG Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1077",
      "journal-title": "Science",
      "key": "79_CR8",
      "unstructured": "Wang DG, Fan J, Siao C, et al: Large scale identification, mapping and genotyping of single-nucleotide polymorphisms in the human genome. Science. 1998, 280: 1077-1082. 10.1126/science.280.5366.1077.",
      "volume": "280",
      "year": "1998"
    },
    {
      "author": "MP Hellio Le Graverand-Gastineau",
      "key": "79_CR9",
      "unstructured": "Hellio Le Graverand-Gastineau MP, Pickering E, Chan G, et al: Prevalence of radiographic osteoarthritis in subjects who are clinically asymptomatic. Abstract OARSI World Congress. 2003, 12-15th October",
      "volume-title": "Abstract OARSI World Congress",
      "year": "2003"
    },
    {
      "DOI": "10.1016/0021-9150(96)05833-9",
      "author": "M Tamminen",
      "doi-asserted-by": "publisher",
      "first-page": "237",
      "journal-title": "Atherosclerosis",
      "key": "79_CR10",
      "unstructured": "Tamminen M, Kakko S, Kesaniemi A, Savolainen MJ: A polymorphic site in the 3' untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity. Atherosclerosis. 1996, 124: 237-247. 10.1016/0021-9150(96)05833-9.",
      "volume": "124",
      "year": "1996"
    },
    {
      "DOI": "10.1136/jmg.2003.016584",
      "author": "JJ McCarthy",
      "doi-asserted-by": "publisher",
      "first-page": "334",
      "journal-title": "J Med Genet",
      "key": "79_CR11",
      "unstructured": "McCarthy JJ, Parker A, Salem R, for the GeneQuest Investigators, et al: Large scale association analysis for identification of genes underlying premature coronary heart disease: Cumulative perspective from analysis of 111 candidate genes. J Med Genet. 2004, 41: 334-341. 10.1136/jmg.2003.016584.",
      "volume": "41",
      "year": "2004"
    },
    {
      "author": "C Jurinke",
      "first-page": "179",
      "journal-title": "Methods Mol Biol",
      "key": "79_CR12",
      "unstructured": "Jurinke C, van den Boom D, Cantor CR, Koster H: The use of MassARRAY technology for high throughput genotyping. Methods Mol Biol. 2002, 187: 179-192.",
      "volume": "187",
      "year": "2002"
    },
    {
      "DOI": "10.1101/gr.1949704",
      "author": "DL Barker",
      "doi-asserted-by": "publisher",
      "first-page": "901",
      "journal-title": "Genome Res",
      "key": "79_CR13",
      "unstructured": "Barker DL, Hansen M, Faruqi AF, et al: Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. Genome Res. 2004, 14: 901-907. 10.1101/gr.1949704.",
      "volume": "14",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.onc.1207329",
      "author": "PA Janne",
      "doi-asserted-by": "publisher",
      "first-page": "2716",
      "journal-title": "Oncogene",
      "key": "79_CR14",
      "unstructured": "Janne PA, Li C, Zhao X, et al: High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene. 2004, 23: 2716-2726. 10.1038/sj.onc.1207329.",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1126/science.1065573",
      "author": "N Patil",
      "doi-asserted-by": "publisher",
      "first-page": "1719",
      "journal-title": "Science",
      "key": "79_CR15",
      "unstructured": "Patil N, Berno AJ, Hinds DA, et al: Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science. 2001, 294: 1719-1723. 10.1126/science.1065573.",
      "volume": "294",
      "year": "2001"
    },
    {
      "author": "JS MacNeil",
      "first-page": "23",
      "journal-title": "Genome Technol",
      "key": "79_CR16",
      "unstructured": "MacNeil JS: (Still) looking for a few new sequencing technologies. Genome Technol. 2004, 46: 23-26.",
      "volume": "46",
      "year": "2004"
    },
    {
      "DOI": "10.1038/90032",
      "author": "JA Robertson",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "journal-title": "Nat Genet",
      "key": "79_CR17",
      "unstructured": "Robertson JA: Consent and privacy in pharmacogenetic testing. Nat Genet. 2001, 28: 207-209. 10.1038/90032.",
      "volume": "28",
      "year": "2001"
    },
    {
      "DOI": "10.1046/j.1365-2265.2002.01610.x",
      "author": "EA McIntyre",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "journal-title": "Clin Endocrinol",
      "key": "79_CR18",
      "unstructured": "McIntyre EA, Walter M: Genetics of type 2 diabetes and insulin resistance: Knowledge from human studies. Clin Endocrinol. 2002, 57: 303-311. 10.1046/j.1365-2265.2002.01610.x.",
      "volume": "57",
      "year": "2002"
    },
    {
      "DOI": "10.1146/annurev.genom.4.070802.110436",
      "author": "JC Florez",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "Annu Rev Genomics Hum Genet",
      "key": "79_CR19",
      "unstructured": "Florez JC, Hirschhorn J, Altshuler D: The inherited basis of diabetes mellitus: Implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet. 2003, 4: 257-291. 10.1146/annurev.genom.4.070802.110436.",
      "volume": "4",
      "year": "2003"
    },
    {
      "author": "DB Allison",
      "first-page": "990",
      "journal-title": "Int J Obes",
      "key": "79_CR20",
      "unstructured": "Allison DB, Faith MS, Nathan JS: Risch's lambda values for human obesity. Int J Obes. 1996, 20: 990-999.",
      "volume": "20",
      "year": "1996"
    },
    {
      "DOI": "10.1023/A:1025635913927",
      "author": "HH Maes",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "journal-title": "Behav Genet",
      "key": "79_CR21",
      "unstructured": "Maes HH, Neale MC, Eaves LJ: Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997, 27: 325-351. 10.1023/A:1025635913927.",
      "volume": "27",
      "year": "1997"
    },
    {
      "DOI": "10.1136/bmj.321.7270.1179",
      "author": "P Lanyon",
      "doi-asserted-by": "publisher",
      "first-page": "1179",
      "journal-title": "BMJ",
      "key": "79_CR22",
      "unstructured": "Lanyon P, Muir K, Doherty S, Doherty M: Assessment of a genetic contribution to osteoarthritis of the hip: Sibling study. BMJ. 2000, 321: 1179-1183. 10.1136/bmj.321.7270.1179.",
      "volume": "321",
      "year": "2000"
    },
    {
      "DOI": "10.1002/1529-0131(200011)43:11\u003c2410::AID-ANR6\u003e3.0.CO;2-E",
      "author": "AJ MacGregor",
      "doi-asserted-by": "publisher",
      "first-page": "2410",
      "journal-title": "Arthritis Rheum",
      "key": "79_CR23",
      "unstructured": "MacGregor AJ, Antoniades L, Matson M, et al: The genetic contribution to radiographic hip osteoarthritis in women. Arthritis Rheum. 2000, 43: 2410-2416. 10.1002/1529-0131(200011)43:11\u003c2410::AID-ANR6\u003e3.0.CO;2-E.",
      "volume": "43",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJM199011013231803",
      "author": "A Inazu",
      "doi-asserted-by": "publisher",
      "first-page": "1234",
      "journal-title": "N Engl J Med",
      "key": "79_CR24",
      "unstructured": "Inazu A, Brown ML, Hesler CB, et al: Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med. 1990, 323: 1234-1238. 10.1056/NEJM199011013231803.",
      "volume": "323",
      "year": "1990"
    },
    {
      "DOI": "10.1172/JCI114764",
      "author": "S Yamashita",
      "doi-asserted-by": "publisher",
      "first-page": "688",
      "journal-title": "J Clin Invest",
      "key": "79_CR25",
      "unstructured": "Yamashita S, Sprecher DL, Sakai N, et al: Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest. 1990, 86: 688-695. 10.1172/JCI114764.",
      "volume": "86",
      "year": "1990"
    },
    {
      "DOI": "10.1038/377065a0",
      "author": "P Macchi",
      "doi-asserted-by": "publisher",
      "first-page": "65",
      "journal-title": "Nature",
      "key": "79_CR26",
      "unstructured": "Macchi P, Villa A, Giliani S, et al: Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature. 1995, 377: 65-68. 10.1038/377065a0.",
      "volume": "377",
      "year": "1995"
    },
    {
      "DOI": "10.1161/01.ATV.0000118278.21719.17",
      "author": "RW Clark",
      "doi-asserted-by": "publisher",
      "first-page": "490",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "79_CR27",
      "unstructured": "Clark RW, Sutfin TA, Ruggeri RB, et al: Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: An initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol. 2004, 24: 490-497. 10.1161/01.ATV.0000118278.21719.17.",
      "volume": "24",
      "year": "2004"
    },
    {
      "DOI": "10.1126/science.1087061",
      "author": "PS Changelian",
      "doi-asserted-by": "publisher",
      "first-page": "875",
      "journal-title": "Science",
      "key": "79_CR28",
      "unstructured": "Changelian PS, Flanagan ME, Ball DJ, et al: Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science. 2003, 30: 875-881.",
      "volume": "30",
      "year": "2003"
    },
    {
      "DOI": "10.1086/342734",
      "author": "H Steffansson",
      "doi-asserted-by": "publisher",
      "first-page": "877",
      "journal-title": "Am J Hum Genet",
      "key": "79_CR29",
      "unstructured": "Steffansson H, Sarginson J, Kong A, et al: Neuregulin I and susceptibility to schizophrenia. Am J Hum Genet. 2002, 71: 877-892. 10.1086/342734.",
      "volume": "71",
      "year": "2002"
    },
    {
      "DOI": "10.1038/ng1245",
      "author": "S Gretarsdottir",
      "doi-asserted-by": "publisher",
      "first-page": "131",
      "journal-title": "Nat Genet",
      "key": "79_CR30",
      "unstructured": "Gretarsdottir S, Thorleifsson G, Reynisdottir ST, et al: The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet. 2003, 35: 131-138. 10.1038/ng1245.",
      "volume": "35",
      "year": "2003"
    },
    {
      "DOI": "10.1056/NEJMoa025079",
      "author": "JH Dwyer",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "N Engl J Med",
      "key": "79_CR31",
      "unstructured": "Dwyer JH, Allayee H, Dwyer KM, et al: Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med. 2004, 350: 29-37. 10.1056/NEJMoa025079.",
      "volume": "350",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.bbalip.2003.12.001",
      "author": "AR Mank-Seymour",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "journal-title": "Biochim Biophys Acta",
      "key": "79_CR32",
      "unstructured": "Mank-Seymour AR, Durham LK, Thompson JF, et al: Association between single-nucleotide polymorphisms in the endothelial lipase (LIPG) gene and high-density lipoprotein cholesterol levels. Biochim Biophys Acta. 2004, 1636: 40-46. 10.1016/j.bbalip.2003.12.001.",
      "volume": "1636",
      "year": "2004"
    },
    {
      "DOI": "10.1006/geno.1995.9003",
      "author": "B Devlin",
      "doi-asserted-by": "publisher",
      "first-page": "311",
      "journal-title": "Genomics",
      "key": "79_CR33",
      "unstructured": "Devlin B, Risch N: A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 1995, 29: 311-322. 10.1006/geno.1995.9003.",
      "volume": "29",
      "year": "1995"
    },
    {
      "DOI": "10.1086/381000",
      "author": "CS Carlson",
      "doi-asserted-by": "publisher",
      "first-page": "106",
      "journal-title": "Am J Hum Genet",
      "key": "79_CR34",
      "unstructured": "Carlson CS, Eberle MA, Rieder MJ, et al: Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004, 74: 106-120. 10.1086/381000.",
      "volume": "74",
      "year": "2004"
    },
    {
      "DOI": "10.1038/35079114",
      "author": "Y Ogura",
      "doi-asserted-by": "publisher",
      "first-page": "603",
      "journal-title": "Nature",
      "key": "79_CR35",
      "unstructured": "Ogura Y, Bonen DK, Inohara N, et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2004, 411: 603-606.",
      "volume": "411",
      "year": "2004"
    },
    {
      "DOI": "10.1186/1479-7364-1-6-421",
      "author": "DA Hinds",
      "doi-asserted-by": "publisher",
      "first-page": "421",
      "journal-title": "Hum Genomics",
      "key": "79_CR36",
      "unstructured": "Hinds DA, Seymour AB, Durham LK, et al: Application of pooled genotyping to scan candidate regions for association with HDL levels. Hum Genomics. 2004, 1: 421-434.",
      "volume": "1",
      "year": "2004"
    },
    {
      "DOI": "10.1126/science.1059431",
      "author": "JC Stephens",
      "doi-asserted-by": "publisher",
      "first-page": "489",
      "journal-title": "Science",
      "key": "79_CR37",
      "unstructured": "Stephens JC, Schneider JA, Tanguay DA, et al: Haplotype variation and linkage disequilibrium in 313 human genes. Science. 2001, 293: 489-493. 10.1126/science.1059431.",
      "volume": "293",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0021-9150(03)00005-4",
      "author": "JF Thompson",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Atherosclerosis",
      "key": "79_CR38",
      "unstructured": "Thompson JF, Lira ME, Durham LK, et al: Polymorphisms in the CETP gene and association with CETP mass and HDL levels. Atherosclerosis. 2003, 167: 195-204. 10.1016/S0021-9150(03)00005-4.",
      "volume": "167",
      "year": "2003"
    },
    {
      "author": "C Sachse",
      "first-page": "284",
      "journal-title": "Am J Hum Genet",
      "key": "79_CR39",
      "unstructured": "Sachse C, Brockmoller J, Bauer S, Roots I: Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences. Am J Hum Genet. 1997, 60: 284-295.",
      "volume": "60",
      "year": "1997"
    },
    {
      "author": "SM McElroy",
      "key": "79_CR40",
      "unstructured": "McElroy SM, Sachse C, Richmond J, et al: Utilization of CYP450 2D6 genotyping as an alternative to probe drug phenotyping for determination of metabolic status in a clinical setting. AAPS Pharmsci. 2000, 2 (33): (Accessed 21st October, 2004), [\n                    http://www.aapsharmsci.org/view.asp?art=ps020433\n                    \n                  ]",
      "volume-title": "Utilization of CYP450 2D6 genotyping as an alternative to probe drug phenotyping for determination of metabolic status in a clinical setting",
      "year": "2000"
    },
    {
      "DOI": "10.1126/science.286.5439.487",
      "author": "WE Evans",
      "doi-asserted-by": "publisher",
      "first-page": "487",
      "journal-title": "Science",
      "key": "79_CR41",
      "unstructured": "Evans WE, Relling MV: Pharmacogenomics: Translating functional genomics into rational therapeutics. Science. 1999, 286: 487-491. 10.1126/science.286.5439.487.",
      "volume": "286",
      "year": "1999"
    },
    {
      "DOI": "10.1258/0007142991902439",
      "author": "CR Wolf",
      "doi-asserted-by": "publisher",
      "first-page": "366",
      "journal-title": "Br Med Bull",
      "key": "79_CR42",
      "unstructured": "Wolf CR, Smith G: Pharmacogenetics. Br Med Bull. 1999, 55: 366-386. 10.1258/0007142991902439.",
      "volume": "55",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0165-6147(99)01363-2",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "publisher",
      "first-page": "342",
      "journal-title": "Trends Pharmacol Sci",
      "key": "79_CR43",
      "unstructured": "Ingelman-Sundberg M, Oscarson M, McLellan RA: Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment. Trends Pharmacol Sci. 1999, 20: 342-349. 10.1016/S0165-6147(99)01363-2.",
      "volume": "20",
      "year": "1999"
    },
    {
      "DOI": "10.1046/j.1365-2796.2001.00879.x",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "publisher",
      "first-page": "186",
      "journal-title": "J Intern Med",
      "key": "79_CR44",
      "unstructured": "Ingelman-Sundberg M: Pharmacogenetics: An opportunity for a safer and more efficient pharmacotherapy. J Intern Med. 2001, 250: 186-200. 10.1046/j.1365-2796.2001.00879.x.",
      "volume": "250",
      "year": "2001"
    },
    {
      "DOI": "10.1046/j.0306-5251.2001.01499.x",
      "author": "JA Goldstein",
      "doi-asserted-by": "publisher",
      "first-page": "349",
      "journal-title": "Br J Clin Pharmacol",
      "key": "79_CR45",
      "unstructured": "Goldstein JA: Clinical relevance of genetic polymorphisms in the human CYP 2C subfamily. Br J Clin Pharmacol. 2001, 52: 349-355. 10.1046/j.0306-5251.2001.01499.x.",
      "volume": "52",
      "year": "2001"
    },
    {
      "DOI": "10.1097/00004714-199910000-00014",
      "author": "V Ozdemir",
      "doi-asserted-by": "publisher",
      "first-page": "472",
      "journal-title": "J Clin Psychopharmacol",
      "key": "79_CR46",
      "unstructured": "Ozdemir V, Tyndale RF, Reed K, et al: Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers. J Clin Psychopharmacol. 1999, 19: 472-475. 10.1097/00004714-199910000-00014.",
      "volume": "19",
      "year": "1999"
    },
    {
      "DOI": "10.1097/00007691-200312000-00014",
      "author": "C Charlier",
      "doi-asserted-by": "publisher",
      "first-page": "738",
      "journal-title": "Ther Drug Monit",
      "key": "79_CR47",
      "unstructured": "Charlier C, Broly F, Lhermitte M, et al: Polymorphisms in the CYP 2D6 gene: Association with plasma concentrations of fluoxetine and paroxetine. Ther Drug Monit. 2003, 25: 738-742. 10.1097/00007691-200312000-00014.",
      "volume": "25",
      "year": "2003"
    },
    {
      "DOI": "10.1038/ng1311",
      "author": "A Helgadottir",
      "doi-asserted-by": "publisher",
      "first-page": "233",
      "journal-title": "Nature Genet",
      "key": "79_CR48",
      "unstructured": "Helgadottir A, Manolescu A, Thorleifsson G, et al: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nature Genet. 2004, 36: 233-239. 10.1038/ng1311.",
      "volume": "36",
      "year": "2004"
    },
    {
      "DOI": "10.1126/science.273.5283.1856",
      "author": "M Dean",
      "doi-asserted-by": "publisher",
      "first-page": "1856",
      "journal-title": "Science",
      "key": "79_CR49",
      "unstructured": "Dean M, Carrington M, Winkter C, et al: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 1996, 273: 1856-1861. 10.1126/science.273.5283.1856.",
      "volume": "273",
      "year": "1996"
    },
    {
      "author": "M Penny",
      "key": "79_CR50",
      "unstructured": "Penny M, Myrand S, Lin C, et al: Pharmacogenetic analysis of polymorphisms in the chemokine receptors CCR5 and CCR2 in the clinical development of a CCR5 antagonist (UK-427, 857) for the treatment of HIV/AIDS. 2004, FDA Science Forum, Washington, DC, USA",
      "volume-title": "Pharmacogenetic analysis of polymorphisms in the chemokine receptors CCR5 and CCR2 in the clinical development of a CCR5 antagonist (UK-427, 857) for the treatment of HIV/AIDS",
      "year": "2004"
    },
    {
      "DOI": "10.1177/0091270003252244",
      "author": "LJ Lesko",
      "doi-asserted-by": "publisher",
      "first-page": "342",
      "journal-title": "J Clin Pharmacol",
      "key": "79_CR51",
      "unstructured": "Lesko LJ, Salerno RA, Spear BB, et al: Pharmacogenetics and pharmacogenomics in drug development and regulatory decision-making: Report of the first FDA-PWG-PhRMA-DruSafe workshop. J Clin Pharmacol. 2003, 43: 342-358. 10.1177/0091270003252244.",
      "volume": "43",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nrd840",
      "author": "AD Roses",
      "doi-asserted-by": "publisher",
      "first-page": "541",
      "journal-title": "Nat Rev Genet",
      "key": "79_CR52",
      "unstructured": "Roses AD: Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Genet. 2002, 1: 541-549. 10.1038/nrd840.",
      "volume": "1",
      "year": "2002"
    },
    {
      "DOI": "10.1038/sj.tpj.6500221",
      "author": "TM Danoff",
      "doi-asserted-by": "publisher",
      "first-page": "49",
      "journal-title": "Pharmacogenomics J",
      "key": "79_CR53",
      "unstructured": "Danoff TM, Campbell DA, McCarthy LC, et al: A Gilbert's syndrome UGT1A1 variant confers susceptibility to Tranilast-induced hyperbilirubinemia. Pharmacogenomics J. 2004, 4: 49-53. 10.1038/sj.tpj.6500221.",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1038/nrg1432",
      "author": "AD Roses",
      "doi-asserted-by": "publisher",
      "first-page": "645",
      "journal-title": "Nat Rev Genet",
      "key": "79_CR54",
      "unstructured": "Roses AD: Pharmacogenetics and drug development: The path to safer and more effective drugs. Nat Rev Genet. 2004, 5: 645-655.",
      "volume": "5",
      "year": "2004"
    },
    {
      "author": "CF Xu",
      "key": "79_CR55",
      "unstructured": "Xu CF, Lewis KF, Yeo AJ, et al: Identification of a pharmacogenetic effect by linkage disequilibrium mapping. Pharmacogenomics J. 2004.",
      "volume-title": "Pharmacogenomics J",
      "year": "2004"
    },
    {
      "DOI": "10.1038/428486a",
      "author": "W-H Chung",
      "doi-asserted-by": "publisher",
      "first-page": "486",
      "journal-title": "Nature",
      "key": "79_CR56",
      "unstructured": "Chung W-H, Hung S-I, Hong H-S, et al: A marker for Stevens-Johnson syndrome. Nature. 2004, 428: 486-10.1038/428486a.",
      "volume": "428",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0009-9236(03)00068-7",
      "author": "JA Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "44",
      "journal-title": "Clin Pharmacol Ther",
      "key": "79_CR57",
      "unstructured": "Johnson JA, Zineh I, Puckett BJ, et al: Beta-1 adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther. 2003, 74: 44-52. 10.1016/S0009-9236(03)00068-7.",
      "volume": "74",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0140-6736(02)07873-X",
      "author": "S Mallal",
      "doi-asserted-by": "publisher",
      "first-page": "727",
      "journal-title": "Lancet",
      "key": "79_CR58",
      "unstructured": "Mallal S, Nolan D, Witt C, et al: Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet. 2002, 359: 727-732. 10.1016/S0140-6736(02)07873-X.",
      "volume": "359",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0140-6736(02)08158-8",
      "author": "S Hetherington",
      "doi-asserted-by": "publisher",
      "first-page": "1121",
      "journal-title": "Lancet",
      "key": "79_CR59",
      "unstructured": "Hetherington S, Hughes AR, Mosteller M, et al: Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet. 2002, 359: 1121-1122. 10.1016/S0140-6736(02)08158-8.",
      "volume": "359",
      "year": "2002"
    },
    {
      "DOI": "10.1093/humrep/deg031",
      "author": "S Palumbo",
      "doi-asserted-by": "publisher",
      "first-page": "192",
      "journal-title": "Hum Reprod",
      "key": "79_CR60",
      "unstructured": "Palumbo S, Giuliano F, Mossetti G, et al: Raloxifene administration in post-menopausal women with osteoporosis: Effect of different BsmI vitamin D receptor genotypes. Hum Reprod. 2003, 18: 192-198. 10.1093/humrep/deg031.",
      "volume": "18",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.tpj.6500123",
      "author": "G Acuna",
      "doi-asserted-by": "publisher",
      "first-page": "327",
      "journal-title": "Pharmacogenomics J",
      "key": "79_CR61",
      "unstructured": "Acuna G, Foernzler D, Leong D, et al: Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity. Pharmacogenomics J. 2002, 2: 327-334. 10.1038/sj.tpj.6500123.",
      "volume": "2",
      "year": "2002"
    },
    {
      "DOI": "10.1159/000028394",
      "author": "EY Krynetski",
      "doi-asserted-by": "publisher",
      "first-page": "136",
      "journal-title": "Pharmacology",
      "key": "79_CR62",
      "unstructured": "Krynetski EY, Evans WE: Genetic polymorphism of thiopurine S-methyltransferase: Molecular mechanisms and clinical importance. Pharmacology. 2000, 61: 136-146. 10.1159/000028394.",
      "volume": "61",
      "year": "2000"
    },
    {
      "DOI": "10.1038/9680",
      "author": "JM Drazen",
      "doi-asserted-by": "publisher",
      "first-page": "168",
      "journal-title": "Nat Genet",
      "key": "79_CR63",
      "unstructured": "Drazen JM, Yandava CN, Dube L, et al: Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet. 1999, 22: 168-170. 10.1038/9680.",
      "volume": "22",
      "year": "1999"
    },
    {
      "DOI": "10.1038/sj.mp.4000425",
      "author": "E Smeraldi",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "journal-title": "Mol Psychiatry",
      "key": "79_CR64",
      "unstructured": "Smeraldi E, Zanardi R, Benedetti F, et al: Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry. 1998, 3: 508-511. 10.1038/sj.mp.4000425.",
      "volume": "3",
      "year": "1998"
    },
    {
      "DOI": "10.1007/s00213-003-1562-3",
      "author": "LK Durham",
      "doi-asserted-by": "publisher",
      "first-page": "525",
      "journal-title": "Psychoparmacol",
      "key": "79_CR65",
      "unstructured": "Durham LK, Webb SM, Milos PM, et al: The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depression. Psychoparmacol. 2004, 174: 525-529.",
      "volume": "174",
      "year": "2004"
    },
    {
      "DOI": "10.1161/01.CIR.98.20.2148",
      "author": "S Ueda",
      "doi-asserted-by": "publisher",
      "first-page": "2148",
      "journal-title": "Circulation",
      "key": "79_CR66",
      "unstructured": "Ueda S, Meredith PA, Morton JJ, et al: ACE (I/D) genotype as a predictor or the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans. Circulation. 1998, 98: 2148-2153. 10.1161/01.CIR.98.20.2148.",
      "volume": "98",
      "year": "1998"
    },
    {
      "DOI": "10.1016/S0959-8049(00)00378-6",
      "author": "PT Iau",
      "doi-asserted-by": "publisher",
      "first-page": "300",
      "journal-title": "Eur J Cancer",
      "key": "79_CR67",
      "unstructured": "Iau PT, Macmillan RD, Blamey RW: Germline mutations associated with breast cancer susceptibility. Eur J Cancer. 2001, 37: 300-321. 10.1016/S0959-8049(00)00378-6.",
      "volume": "37",
      "year": "2001"
    },
    {
      "DOI": "10.1126/science.1096096",
      "author": "Z Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1164",
      "journal-title": "Science",
      "key": "79_CR68",
      "unstructured": "Wang Z, Shen D, Parsons DW, et al: Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science. 2004, 304: 1164-1166. 10.1126/science.1096096.",
      "volume": "304",
      "year": "2004"
    },
    {
      "DOI": "10.1126/science.1099314",
      "author": "JG Paez",
      "doi-asserted-by": "publisher",
      "first-page": "1497",
      "journal-title": "Science",
      "key": "79_CR69",
      "unstructured": "Paez JG, Psai A, Janne PA: EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science. 2004, 304: 1497-1500. 10.1126/science.1099314.",
      "volume": "304",
      "year": "2004"
    },
    {
      "DOI": "10.1126/science.1082596",
      "author": "A Bardelli",
      "doi-asserted-by": "publisher",
      "first-page": "949",
      "journal-title": "Science",
      "key": "79_CR70",
      "unstructured": "Bardelli A, Parsons DW, Silliman N, et al: Mutational analysis of the tyrosine kinome in colorectal cancers. Science. 2003, 300: 949-10.1126/science.1082596.",
      "volume": "300",
      "year": "2003"
    },
    {
      "DOI": "10.1038/ng1054",
      "author": "PM Pollock",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "journal-title": "Nat Genet",
      "key": "79_CR71",
      "unstructured": "Pollock PM, Harper UL, Hansen KS, et al: High frequency of BRAF mutations in nevi. Nat Genet. 2002, 33: 19-20.",
      "volume": "33",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.3798106",
      "author": "DJ Slamon",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "journal-title": "Science",
      "key": "79_CR72",
      "unstructured": "Slamon DJ, Clark GM, Wong SG, et al: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987, 235: 177-182. 10.1126/science.3798106.",
      "volume": "235",
      "year": "1987"
    },
    {
      "DOI": "10.1007/BF00918679",
      "author": "HM Shepard",
      "doi-asserted-by": "publisher",
      "first-page": "117",
      "journal-title": "J Clin Immunol",
      "key": "79_CR73",
      "unstructured": "Shepard HM, Lewis GD, Sarup JC, et al: Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic. J Clin Immunol. 1991, 11: 117-127. 10.1007/BF00918679.",
      "volume": "11",
      "year": "1991"
    },
    {
      "author": "MA Molina",
      "first-page": "4744",
      "journal-title": "Cancer Res",
      "key": "79_CR74",
      "unstructured": "Molina MA, Codony-Servat J, Albanell J, et al: Trastuzumab (herceptin), a humanized antiHer2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells. Cancer Res. 2001, 61: 4744-4749.",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.1999.17.9.2639",
      "author": "MA Cobleigh",
      "doi-asserted-by": "crossref",
      "first-page": "2639",
      "journal-title": "J Clin Oncol",
      "key": "79_CR75",
      "unstructured": "Cobleigh MA, Vogel CL, Tripathy D, et al: Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol. 1999, 17: 2639-2648.",
      "volume": "17",
      "year": "1999"
    },
    {
      "DOI": "10.1038/243290a0",
      "author": "JD Rowley",
      "doi-asserted-by": "publisher",
      "first-page": "290",
      "journal-title": "Nature",
      "key": "79_CR76",
      "unstructured": "Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giesma staining. Nature. 1973, 243: 290-293. 10.1038/243290a0.",
      "volume": "243",
      "year": "1973"
    },
    {
      "DOI": "10.1056/NEJMoa011573",
      "author": "H Kantarjian",
      "doi-asserted-by": "publisher",
      "first-page": "645",
      "journal-title": "N Engl J Med",
      "key": "79_CR77",
      "unstructured": "Kantarjian H, Sawyers C, Hochhaus A, et al: Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukaemia. N Engl J Med. 2002, 346: 645-652. 10.1056/NEJMoa011573.",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.1062538",
      "author": "ME Gorre",
      "doi-asserted-by": "publisher",
      "first-page": "876",
      "journal-title": "Science",
      "key": "79_CR78",
      "unstructured": "Gorre ME, Mohammed M, Ellwood K, et al: Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science. 2001, 293: 876-880. 10.1126/science.1062538.",
      "volume": "293",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0140-6736(02)07679-1",
      "author": "NV Bubnoff",
      "doi-asserted-by": "publisher",
      "first-page": "487",
      "journal-title": "Lancet",
      "key": "79_CR79",
      "unstructured": "Bubnoff NV, Schneller F, Peschel C, Duyster J: BCRABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: A prospective study. Lancet. 2002, 359: 487-491. 10.1016/S0140-6736(02)07679-1.",
      "volume": "359",
      "year": "2002"
    },
    {
      "DOI": "10.1182/blood.V99.9.3472",
      "author": "S Branford",
      "doi-asserted-by": "publisher",
      "first-page": "3472",
      "journal-title": "Blood",
      "key": "79_CR80",
      "unstructured": "Branford S, Rudzki Z, Walsh S, et al: High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood. 2002, 99: 3472-3475. 10.1182/blood.V99.9.3472.",
      "volume": "99",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJMoa040938",
      "author": "TJ Lynch",
      "doi-asserted-by": "publisher",
      "first-page": "350",
      "journal-title": "N Engl J Med",
      "key": "79_CR81",
      "unstructured": "Lynch TJ, Bell DW, Sordella R, et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004, 350: 350-361.",
      "volume": "350",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ng1060",
      "author": "S Ramaswamy",
      "doi-asserted-by": "publisher",
      "first-page": "49",
      "journal-title": "Nat Genet",
      "key": "79_CR82",
      "unstructured": "Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid. Nat Genet. 2003, 33: 49-54. 10.1038/ng1060.",
      "volume": "33",
      "year": "2003"
    }
  ],
  "reference-count": 82,
  "references-count": 82,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/1479-7364-1-6-444"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Emerging strategies and applications of pharmacogenomics"
  ],
  "type": "journal-article",
  "volume": "1"
}